by Christine Stackhouse | Oct 24, 2023
On October 24, 2023, Partner Jolie Apicella was quoted in the Health Payer Intelligence article titled, “What Cigna’s FCA Settlement Means for Other Medicare Advantage Plans.” Regarding Cigna’s recent False Claims Act settlement, Jolie...
by Christine Stackhouse | Oct 20, 2023
On October 20, 2023, Partner Paul Tuchmann was quoted in the Business Insider article titled, “Sam Bankman-Fried has less than a week to decide if he’ll testify in his trial. If he lies, he could get a longer prison sentence.” In regards to...
by Kelly Sweeney | Oct 17, 2023
Wiggin and Dana recently represented Notable Labs, Inc. (Notable), a clinical stage therapeutics platform company developing predictive precision medicines for cancer patients, in its merger with VBL Therapeutics (Nasdaq: VBLT) and associated financing transaction....
by Christine Stackhouse | Oct 16, 2023
On October 10-13, 2023, Partner Paul Tuchmann was quoted in Law360 and The New York Times regarding Sam Bankman-Fried’s criminal fraud trial in Manhattan. In the October 13 Law360 article titled, “Bankman-Fried Notches Small...
by Kelly Sweeney | Oct 10, 2023
Wiggin and Dana is proud to announce that Partners Joseph Casino and Michael Kasdan and Consulting Counsel Takao Saito have been named as world-leading IP Strategists in the 2023 edition of the IAM Strategy 300 – The World’s Leading IP...
